File(s) under embargo

10

month(s)

until file(s) become available

Health economic modelling of oncology therapies

thesis
posted on 28.03.2022, 03:08 by HANSOO KIM
The treatment of cancer has evolved from non-specific chemotherapy to immune checkpoint inhibitors. The costs of newer treatments are high and access is challenging for payers as there are many uncertainties relating to efficacy, safety and benefits to patients’ quality of life. Health technology assessment incorporating health economic modelling is pivotal for managing the financial risks of oncology treatments, but better methods are needed to ensure timely access to appropriate new oncology therapies. This work highlights the key issues pertaining to health economic modelling and offers potential solutions.

History

Principal supervisor

Danny Liew

Additional supervisor 1

Stephen Goodall

Year of Award

2022

Department, School or Centre

Public Health and Preventive Medicine

Additional Institution or Organisation

School of Public Health and Preventive Medicine

Campus location

Australia

Course

Doctor of Philosophy

Degree Type

DOCTORATE

Faculty

Faculty of Medicine, Nursing and Health Sciences

Usage metrics

Exports